BOS-580

· Boston Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BOS-580, covering 2025-10-30 to 2025-10-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension [Phase 2]

See pricing